Left Main PCI: Despite Auspicious Long-Term Outcomes, Optimal Strategy Still under Discussion

Left main coronary artery bifurcation interventions have shown very good results at long term, especially with new generation DES. The one-stent strategy has seen better results than the two-stent strategy, according to this registry recently published in J Am Coll Cardiol Intv. However, how does this registry of the daily practice between the years 2002 and 2013 impact the daily practice in 2018?

Angioplastia de tronco: aún con buenos resultados a largo plazo, la estrategia óptima sigue en discusiónMultiple studies have compared different two-stent techniques to treat bifurcations, but the first to consider the provisional stent technique for all patients was the SMART-STRATEGY trial (randomization was after stent implantation in the main branch), published in 2012, in J Am Coll Cardiol Intv.

 

This study at 3 years provided us with more aggressive criteria, or more conservative, to salvage the side branch, but always with an initial provisional stent strategy. The SMART-STRATEGY of course included patients with left main lesions. For about 5 years, the left main coronary artery seemed simply the largest bifurcation, but at TCT 2017 the DKCRUSH-V was presented and simultaneously published in J Am Coll Cardiol, showing the two-stent technique was superior to provisional stenting, and we had to reconsider. Literature, technique and devices are constantly being advanced, and we need to keep up.


Read also: EXCEL Sub-Study: The Site of the Left Main Coronary Artery Lesion Does Not Alter History.


The present registry (with all of registries’ virtues and limitations) assessed the long-term outcomes of left main PCI, focusing on the kind of stent and, of course, the optimal technique to treat bifurcations.

 

The registry included 1353 ‘real life’ patients treated with different techniques and with different generation stents. Primary endpoint was a composite of cardiac death, infarction, stent thrombosis and target vessel revascularization at 3 years. Patient characteristics were adjusted using propensity score.

 

The one-stent strategy had better clinical results than the two-stent strategy (4.7% vs. 18.6%, HR: 3.71; CI 95%: 2.55 to 5.39; p < 0.001) and new generation DES had better results than old DES (4.6% vs. 10.9%, HR: 0.55; CI 95%: 0.34 to 0.89; p=0.014). The difference between DES generations was more obvious when using the 2 stent technique. For patients with contemporary DES, the presence of kidney failure and preintervention side branch ≥50% diameter stenosis were independent predictors of major events.


Read also: Post-Dilation in Valve-in-Valve Implantation Offers Hemodynamic Improvement.


Meanwhile, the DKCRUSH-V sub-studies are coming out and of course we look forward to seeing their long terms outcomes (so far, we only have data at one year).

 

Original title: Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting.

Reference: Sungsoo Cho et al. J Am Coll Cardiol Intv 2018;11:1247–58.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...